| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(96)00214-9 |
| P698 | PubMed publication ID | 9178456 |
| P50 | author | Kathleen Neuzil | Q76169016 |
| Barney S. Graham | Q89108863 | ||
| P2093 | author name string | Fischer JE | |
| Parker RA | |||
| Tang YW | |||
| Robinson FW | |||
| P2860 | cites work | Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo | Q59054431 |
| Cytokine-specific ELISPOT assay. Single cell analysis of IL-2, IL-4 and IL-6 producing cells | Q70625501 | ||
| Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development | Q70960222 | ||
| Susceptibility to Leishmania major infection in interleukin-4-deficient mice | Q70960225 | ||
| Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus | Q34157386 | ||
| Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice | Q34199969 | ||
| Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine | Q34206177 | ||
| Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. | Q36330347 | ||
| Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens | Q36355614 | ||
| Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice | Q36362141 | ||
| Distinct types of lung disease caused by functional subsets of antiviral T cells | Q36362647 | ||
| T cell and non-T cell compartments can independently determine resistance to Leishmania major | Q36364627 | ||
| Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells | Q36687435 | ||
| Prospects for a respiratory syncytial virus vaccine | Q40625380 | ||
| An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine | Q40940832 | ||
| Immunological determinants of disease caused by respiratory syncytial virus | Q41129996 | ||
| Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. | Q41547198 | ||
| Reinfection of mice with respiratory syncytial virus | Q42102570 | ||
| Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial | Q44195643 | ||
| Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population | Q45823296 | ||
| Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine | Q45823297 | ||
| Primary respiratory syncytial virus infection in mice | Q45833440 | ||
| P433 | issue | 6-7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 597-602 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus | |
| P478 | volume | 15 |
| Q26775152 | Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease |
| Q37192233 | Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model |
| Q31123002 | Cytokine expression in respiratory syncytial virus-infected mice as measured by quantitative reverse-transcriptase PCR. |
| Q59349610 | Disruption of the Airway Epithelial Barrier in a Murine Model of Respiratory Syncytial Virus Infection |
| Q34999264 | NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus |
| Q35898832 | Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus |
| Q34204623 | Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development |
| Q34151000 | Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV. |
| Q33820420 | Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. |
| Q73502909 | Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in mice |
| Q30448968 | Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV |
Search more.